-
the development of new radiopharmaceuticals, radiochemistry methodology and translation of lead agents for biomedical imaging. The incumbent will also participate in ongoing radiochemistry procedures for current
-
the development of new radiopharmaceuticals, radiochemistry methodology and translation of lead agents for biomedical imaging. The incumbent will also participate in ongoing radiochemistry procedures for current
-
, acute kidney injury transition to renal fibrosis); as well as high-throughput screening strategies to identify small molecular compounds that might serve as novel therapeutic agents in disease using cell
-
, acute kidney injury transition to renal fibrosis); as well as high-throughput screening strategies to identify small molecular compounds that might serve as novel therapeutic agents in disease using cell
-
, acute kidney injury transition to renal fibrosis); as well as high-throughput screening strategies to identify small molecular compounds that might serve as novel therapeutic agents in disease using cell